{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:36:14Z","timestamp":1788068174378,"version":"build-2784847793"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review summarizes the recent evidence regarding the epidemiology of inflammatory bowel disease (IBD) associated sacroiliitis, including the prevalence, pathogenesis, role of imaging, and therapeutic challenges.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Sacroiliitis is an underappreciated musculoskeletal manifestation of IBD, a chronic inflammatory condition of the gut affecting the younger population. Untreated sacroiliitis can lead to joint destruction and chronic pain, further adding to morbidity in IBD patients. Recent publications suggest sacroiliitis can be detected on abdominal imaging obtained in IBD patients to study bowel disease, but only a small fraction of these patients were seen by rheumatologists. Early detection of IBD-associated sacroiliitis could be achieved by utilization of clinical screening tools in IBD clinics, careful examination of existing computed tomography and MRI studies, and timely referral to rheumatologist for further evaluation and treatment. Current treatment approaches for IBD and sacroiliitis include several targeted biologic therapies, but IBD-associated sacroiliitis has limited options, as these therapies may not overlap in both conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>With the advances in imaging, sacroiliitis is an increasingly recognized comorbidity in IBD patients. Future studies focusing on this unique patient population will expand our understanding of complex pathophysiology of IBD-associated sacroiliitis and lead to identification of novel targeted therapies for this condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001017","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:46:11Z","timestamp":1714491971000},"page":"274-281","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Sacroiliitis in inflammatory bowel disease"],"prefix":"10.1097","volume":"36","author":[{"given":"Fardina","family":"Malik","sequence":"first","affiliation":[{"name":"Division of Rheumatology, New York University Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Weisman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine (Baltimore)"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/art.23523","article-title":"Impact of ankylosing spondylitis on work and family life: comparisons with the US population","volume":"59","author":"Ward","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10067-005-1150-5","article-title":"Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients","volume":"25","author":"Ozg\u00fcl","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/rheumatology\/keac473","article-title":"Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: secondary care cross-sectional study","volume":"62","author":"Lim","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.20990","article-title":"The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?","volume":"52","author":"Rudwaleit","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"R8-20250526","first-page":"631","article-title":"The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Karreman","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R9-20250526","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X21996973","article-title":"Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review","volume":"13","author":"Evans","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s100670070003","article-title":"Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study","volume":"19","author":"Queiro","year":"2000","journal-title":"Clin Rheumatol"},{"key":"R11-20250526","first-page":"949","article-title":"Occult radiological sacroiliac abnormalities in patients with inflammatory bowel disease who do not present signs or symptoms of axial spondylitis","volume":"32","author":"Bandinelli","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0899-7071(95)00046-S","article-title":"Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography","volume":"19","author":"McEniff","year":"1995","journal-title":"Clin Imaging"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/annrheumdis-2016-210747","article-title":"Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis","volume":"76","author":"Sepriano","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3899\/jrheum.120321","article-title":"Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based study","volume":"39","author":"Shivashankar","year":"2012","journal-title":"J Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ecco-jcc\/jjx126","article-title":"Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: results from 20 years of follow-up in the IBSEN Study","volume":"12","author":"Ossum","year":"2018","journal-title":"J Crohns Colitis"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/ibd\/izy339","article-title":"The prevalence and clinical associations of subclinical sacroiliitis in inflammatory bowel disease","volume":"25","author":"Kelly","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/acr.23323","article-title":"Prevalence of sacroiliitis in inflammatory bowel disease using a standardized computed tomography scoring system","volume":"70","author":"Chan","year":"2018","journal-title":"Arthritis Care Res"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3899\/jrheum.220362","article-title":"Identifying axial spondyloarthritis in patients with inflammatory bowel disease using computed tomography","volume":"50","author":"Lim","year":"2023","journal-title":"J Rheumatol"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ibd.20529","article-title":"Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography","volume":"14","author":"Bruining","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00261-011-9832-8","article-title":"Crohn's disease: prevalence of intestinal and extraintestinal manifestations detected by computed tomography enterography with water enema","volume":"37","author":"Paparo","year":"2012","journal-title":"Abdom Imaging"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5009\/gnl.2010.4.3.338","article-title":"Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement","volume":"4","author":"Hwangbo","year":"2010","journal-title":"Gut Liver"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12664-015-0598-8","article-title":"Extraintestinal manifestations in inflammatory bowel disease: prevalence and predictors in Indian patients","volume":"34","author":"Bandyopadhyay","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/1756-185X.14081","article-title":"Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: a cross-sectional study","volume":"24","author":"Malik","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2036.2008.03868.x","article-title":"The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease","volume":"29","author":"Orchard","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00296-022-05208-y","article-title":"Screening for spondyloarthritis in patients with inflammatory bowel diseases","volume":"43","author":"Ottaviani","year":"2023","journal-title":"Rheumatol Int"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/apt.12680","article-title":"The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients","volume":"39","author":"Leclerc-Jacob","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jmri.24762","article-title":"Utilizing MR enterography for detection of sacroiliitis in patients with inflammatory bowel disease","volume":"42","author":"Gotler","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ibd\/izaa198","article-title":"Prevalence, predictors, and disease activity of sacroiliitis among patients with Crohn's disease","volume":"27","author":"Levine","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"(S9)","key":"R30-20250526","first-page":"3697","article-title":"MRI confirms MRE evidence of sacroiliitis in many with Crohn's disease: a prospective study for the screening of axSpA in high-risk populations","volume":"75","author":"Malik","year":"2023","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.17.2.209","article-title":"Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases","volume":"17","author":"Wilkinson","year":"1958","journal-title":"Ann Rheum Dis"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/art.1780030109","article-title":"Spondylitis in chronic ulcerative colitis","volume":"3","author":"Zvaifler","year":"1960","journal-title":"Arthritis Rheum"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/art.1780370105","article-title":"High frequency of silent inflammatory bowel disease in spondylarthropathy","volume":"37","author":"Leirisalo-Repo","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R34-20250526","first-page":"2266","article-title":"The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","article-title":"Long-term evolution of gut inflammation in patients with spondyloarthropathy","volume":"110","author":"De Vos","year":"1996","journal-title":"Gastroenterology"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N Engl J Med"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2004.028837","article-title":"CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease","volume":"64","author":"Laukens","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"e67505","DOI":"10.1371\/journal.pone.0067505","article-title":"IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/ard.2007.080283","article-title":"The IL23R Arg381Gln nonsynonymous polymorphism confers susceptibility to ankylosing spondylitis","volume":"67","author":"Rueda","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.13020","article-title":"The interplay between HLA-B27 and ERAP1\/ERAP2 aminopeptidases: from antiviral protection to spondyloarthritis","volume":"190","author":"Vitulano","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1753425917716527","article-title":"ERAP1 and HLA-C interaction in inflammatory bowel disease in the Spanish population","volume":"23","author":"Castro-Santos","year":"2017","journal-title":"Innate Immun"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1534\/genetics.110.122549","article-title":"One hundred years of pleiotropy: a retrospective","volume":"186","author":"Stearns","year":"2010","journal-title":"Genetics"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/MIB.0000000000000090","article-title":"IBD candidate genes and intestinal barrier regulation","volume":"20","author":"McCole","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J Exp Med"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2019-215210","article-title":"Evidence that tissue resident human enthesis ((T-cells can produce IL-17A independently of IL-23R transcript expression","volume":"78","author":"Cuthbert","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.40150","article-title":"Brief Report: Group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/art.39464","article-title":"Sexual dimorphism in the Th17 signature of ankylosing spondylitis","volume":"68","author":"Gracey","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jir.1998.18.219","article-title":"Transgenic mice expressing a truncated Peromyscus leucopus TNF-alpha gene manifest an arthritis resembling ankylosing spondylitis","volume":"18","author":"Crew","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0140-6736(92)90999-J","article-title":"Tumour necrosis factor alpha in stool as a marker of intestinal inflammation","volume":"339","author":"Braegger","year":"1992","journal-title":"Lancet"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/08923979209005404","article-title":"Serum tumor necrosis factor activity in inflammatory bowel disease","volume":"14","author":"Maeda","year":"1992","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease","volume":"8","author":"Cho","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss Inflammatory Bowel Disease Cohort","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R66-20250526","doi-asserted-by":"crossref","first-page":"e4267","DOI":"10.1097\/MD.0000000000004267","article-title":"Clinical features of Crohn disease concomitant with ankylosing spondylitis: a preliminary single-center study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R67-20250526","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"key":"R68-20250526","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/gut.17.11.906","article-title":"Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27)","volume":"17","author":"Mallas","year":"1976","journal-title":"Gut"},{"key":"R69-20250526","doi-asserted-by":"crossref","first-page":"105367","DOI":"10.1016\/j.jbspin.2022.105367","article-title":"Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn's disease: clinical and MRI results from a prospective inception cohort","volume":"89","author":"Rios Rodriguez","year":"2022","journal-title":"Joint Bone Spine"},{"key":"R70-20250526","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","article-title":"Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases","volume":"111","author":"Monnet","year":"2004","journal-title":"Ophthalmology"},{"key":"R71-20250526","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.gastro.2013.10.055","article-title":"Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease","volume":"146","author":"Ord\u00e1s","year":"2014","journal-title":"Gastroenterology"},{"key":"R72-20250526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R73-20250526","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/acr.24025","article-title":"2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R74-20250526","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","article-title":"AGA Clinical Practice Guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease","volume":"160","author":"Feuerstein","year":"2021","journal-title":"Gastroenterology"},{"key":"R75-20250526","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA Clinical Practice Guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"key":"R76-20250526","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA Clinical Practice Guidelines on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"key":"R77-20250526","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/ph3041084","article-title":"Non steroidal anti-inflammatory drugs and inflammatory bowel disease","volume":"3","author":"Klein","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"R78-20250526","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00228-009-0719-3","article-title":"Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?","volume":"65","author":"Kefalakes","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R79-20250526","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: management of Crohn's disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R80-20250526","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/apt.14606","article-title":"Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation","volume":"47","author":"Moninuola","year":"2018","journal-title":"Aliment Pharmacol Therap"},{"key":"R81-20250526","first-page":"Cd007744","article-title":"Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease","author":"Miao","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R82-20250526","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","article-title":"Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease","volume":"13","author":"Olivieri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R83-20250526","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"R84-20250526","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s10620-015-4007-z","article-title":"Inflammatory bowel disease provoked by etanercept: report of 443 possible cases combined from an IBD referral center and the FDA","volume":"61","author":"O\u2019Toole","year":"2016","journal-title":"Dig Dis Sci"},{"key":"R85-20250526","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"R86-20250526","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"R87-20250526","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","article-title":"Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying antirheumatic drugs (COAST-V): 16\u200aweek results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"R88-20250526","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/annrheumdis-2020-217927","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"79","author":"Fauny","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R89-20250526","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/annrheumdis-2018-214273","article-title":"Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials","volume":"78","author":"Schreiber","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R90-20250526","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/art.41923","article-title":"Risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis\/ankylosing spondylitis initiating interleukin-17 inhibitors: a nationwide population-based study using the French National Health Data System","volume":"74","author":"Penso","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R91-20250526","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn's disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"R92-20250526","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJMc1915042","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"382","author":"Rowan","year":"2020","journal-title":"N Engl J Med"},{"key":"R93-20250526","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","article-title":"Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R94-20250526","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R95-20250526","doi-asserted-by":"crossref","first-page":"614255","DOI":"10.3389\/fimmu.2021.614255","article-title":"Why inhibition of IL-23 lacked efficacy in ankylosing spondylitis","volume":"12","author":"McGonagle","year":"2021","journal-title":"Front Immunol"},{"key":"R96-20250526","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/rheumatology\/key267","article-title":"Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease","volume":"58","author":"Dubash","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R97-20250526","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1136\/annrheumdis-2016-211011","article-title":"Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease","volume":"76","author":"Orlando","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R98-20250526","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","article-title":"Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial","volume":"8","author":"Feagan","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:16:36Z","timestamp":1748294196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001017","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}